Platelet-rich plasma (PRP) · Lesson 17 of 25 · 3 min

PRP for sexual wellness: what is known and what is still investigational

PRP is being studied for erectile dysfunction and several female pelvic health conditions. The evidence is early, and urology societies still class these uses as experimental.

Gloved hands placing a sample tube into a centrifuge

Key takeaways.

  • PRP for sexual wellness remains largely investigational for men and women.
  • Erectile dysfunction has the most data, with meta-analyses reporting improved IIEF scores at 6 months.
  • Female applications rely on early-stage research with small samples.
  • Major urology societies typically classify PRP in this area as experimental.
  • A 2024 safety review of 1,099 people found only mild, short-lived side effects.
  • Thorough informed consent about investigational status is essential.

Why PRP is being studied here

Platelet-rich plasma (PRP) concentrates growth factors from the patient's own platelets. In genital tissue, these factors are proposed to support new blood vessel growth, cell proliferation and tissue repair.

For erectile dysfunction, the theory is that PRP may address the vascular cause by improving blood vessel density and function in the erectile tissue. For female conditions, the theory centers on tissue integrity, blood supply and immune modulation.

Male applications

Erectile dysfunction is the most studied use. Meta-analyses have reported improvements of 2.99 to 3.47 points on the International Index of Erectile Function (IIEF), a standard questionnaire, sustained at 6 months.

PRP is also being studied for Peyronie's disease, a condition of penile scar tissue and curvature. Clinical guidelines from the American Urological Association and the European Association of Urology typically classify PRP as experimental pending better evidence.

Female applications

Research has explored PRP for stress urinary incontinence, lichen sclerosus (a chronic vulvar skin condition) and genitourinary syndrome of menopause. This work is early-stage and limited by small samples and differences between studies.

For female sexual dysfunction more broadly, controlled trial evidence remains limited.

Safety and regulatory status

A 2024 systematic review covering 1,099 people treated across sexual wellness indications found only mild, transient side effects and no major adverse events. Commonly reported effects are injection pain, swelling and bruising. Active infection at the treatment site is a contraindication.

PRP applications are considered off-label, and PRP is not an approved standard-of-care treatment for most of these conditions. Patients should be told clearly that the treatment is investigational and what the evidence does and does not show.

Educational content for healthcare professionals. Not a treatment recommendation. PRP applications are considered off-label.

Platelet-rich plasma (PRP): 0 of 25 lessons finished

All lessons

This guide covers the what and the why.

The how is taught live. The webinar and live training go deeper on:

  • Condition-by-condition review of the male and female evidence
  • Anatomy and injection approach for each indication
  • Preparation choices for sexual wellness applications
  • Contraindications and patient selection
  • Informed consent language for investigational treatment

Common questions.

Is PRP an approved treatment for erectile dysfunction?
No. PRP applications are considered off-label, and major urology guidelines typically classify PRP for erectile dysfunction as experimental pending further high-quality evidence.
What does the research show for PRP in erectile dysfunction?
Meta-analyses have reported IIEF score improvements of 2.99 to 3.47 points sustained at 6 months. Preparation methods and treatment regimens vary across studies, which limits firm recommendations.
Is PRP safe for sexual wellness applications?
A 2024 systematic review of 1,099 people found only mild, transient side effects and no major adverse events. Long-term data and standardized protocols are still lacking.

Sources

  • Masterson TA, et al. A randomized, double-blind, placebo-controlled trial of intracavernosal injection of platelet-rich plasma for the treatment of erectile dysfunction. J Urol. 2023;209(4):773-781.
  • Wang H, et al. Efficacy and safety of platelet-rich plasma for the treatment of erectile dysfunction: a systematic review and meta-analysis. Sex Med Rev. 2024;12(2):245-256.
  • Poulios E, et al. Platelet-rich plasma (PRP) for the treatment of Peyronie's disease: a comprehensive review of the literature. Sex Med Rev. 2023;11(3):298-310.

Ready for the hands-on detail?

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.